Latin America Implantable Cardioverter Defibrillators Market Size & Outlook
Related Markets
Latin America implantable cardioverter defibrillators market highlights
- The Latin America implantable cardioverter defibrillators market generated a revenue of USD 272.4 million in 2023.
- The market is expected to grow at a CAGR of 5.4% from 2024 to 2030.
- In terms of segment, transvenous implantable cardioverter-defibrillators was the largest revenue generating product in 2023.
- Subcutaneous Implantable Cardioverter Defibrillators is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 272.4 million |
| Market revenue in 2030 | USD 392.7 million |
| Growth rate | 5.4% (CAGR from 2023 to 2030) |
| Largest segment | Transvenous implantable cardioverter-defibrillators |
| Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
Other key industry trends
- In terms of revenue, Latin America region accounted for 7.2% of the global implantable cardioverter defibrillators market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,236.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Cardioverter Defibrillators Market Scope
Implantable Cardioverter Defibrillators Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MicroPort Scientific Corp | View profile | 8230 | 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 | https://www.microport.com |
| BIOTRONIK | View profile | 5001-10000 | Berlin, Berlin, Germany, Europe | https://www.biotronik.com/de-de |
| LivaNova PLC | View profile | 2900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | https://www.livanova.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Latin America implantable cardioverter defibrillators market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 90.05% in 2023. Horizon Databook has segmented the Latin America implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
A study published in the European Heart Journal in August 2022 provided insights into the incidence and mortality rates of CVD across various countries in Latin America. The study revealed variations in the incidence and mortality rates, with different countries experiencing different levels of CVD burden.
Brazil had the highest incidence of CVD (3.86 per 1000 person-years), indicating a significant disease prevalence. On the other hand, Argentina had the lowest incidence (3.07 per 1000 person-years). Regarding mortality rates, Argentina had the highest rate (5.98 per 1000 person-years), while Chile had the lowest rate (4.07 per 1000 person-years).
Furthermore, the study highlighted that men had a higher incidence and mortality rate of CVD than women. Men had an incidence rate of 4.48 per 1000 person-years and a mortality rate of 6.33 per 1000 person-years, whereas women had an incidence rate of 2.60 per 1000 person-years and a mortality rate of 3.96 per 1000 person-years.
Reasons to subscribe to Latin America implantable cardioverter defibrillators market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America implantable cardioverter defibrillators market databook
-
Our clientele includes a mix of implantable cardioverter defibrillators market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America implantable cardioverter defibrillators market size, by country, 2018-2030 (US$M)
Latin America Implantable Cardioverter Defibrillators Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
